Lactogenesis II is the onset of copious milk production (i.e., the milk "coming in"), which usually occurs between 30 to 40 hours postpartum. When lactogenesis II fails to occur or is delayed, it may be due to a number of underlying hormonal or non-hormonal conditions. Of the various hormonal etiologies, many can be identified with the aid of a few standard blood tests. Gestational ovarian theca lutein cysts may cause delayed lactogenesis II and are fairly easily detected by ordering testosterone levels. Although this condition can delay lactogenesis II for as long as 31 days, with proper management women affected by these cysts have established breastfeeding. Three of the four women reviewed in this article were eventually able to produce 100% of their infants' caloric requirements.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jmwh.2003.12.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Does Antenatal Expressing Affect Onset of Lactogenesis for Women With Diabetes? Results From a Randomised Controlled Trial and Cohort Study.
Aust N Z J Obstet Gynaecol
December 2024
Judith Lumley Centre, School of Nursing and Midwifery, La Trobe University, Melbourne, Victoria, Australia.
Background: Previously it was recognised onset of Lactogenesis II was delayed in women with Type I diabetes compared to women without diabetes, but the effect of gestational diabetes was unclear. Some clinicians suggest pregnant women with diabetes express breastmilk in late pregnancy to hasten onset of Lactogenesis II.
Aims: To confirm if Lactogenesis II occurs later in women with diabetes in pregnancy, and test if advice to express antenatally hastens Lactogenesis II.
Delayed Lactogenesis II in High-Risk Pregnancies: What Should We Care.
Biol Res Nurs
November 2024
Department of Obstetrics, The First Affiliated Hospital of Soochow University, Suzhou, China.
The timely initiation of lactogenesis II is crucial for postpartum women, with delays having significant clinical implications. This study aimed to evaluate the determinants of delayed lactogenesis II (DOL II) in high-risk pregnant women to guide clinical interventions and postnatal care protocols. We conducted a study involving high-risk pregnant women who gave birth and were admitted to our hospital''s obstetric intensive care unit for postpartum surveillance and treatment from February 1, 2023, to April 30, 2024.
View Article and Find Full Text PDFPotential effect of immediate postpartum use of injectable contraception on lactogenesis.
Contraception
February 2025
The Ohio State University, College of Medicine, Columbus, OH, USA.
Article Synopsis
- The study aimed to investigate how immediate postpartum use of depot medroxyprogesterone acetate (DMPA) affects the timing of lactogenesis stage II (LS-II), which is when milk production starts to increase significantly in new mothers.
- Initially, participants were randomly assigned to receive DMPA, a placebo, or no injection, but due to low enrollment, the design shifted to a nonrandomized approach that still aimed for comparable groups using matching and propensity scoring.
- Results showed that the average time to LS-II was slightly shorter for the DMPA group (57.8 hours) compared to the control group (64.1 hours), but the findings indicated no significant negative impact
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!